Journal of Agricultural and Food Chemistry
Article
adjusted to acidity by adding hydrochloric acid to obtain hapten1 with
and 0.001 mM KLH were dissolved in 0.1 M sodium bicarbonate
solution. After stirring for 10 min, 42 μL of 25% glutaraldehyde was
dropwise added and stirred at room temperature for 24 h. The
conjugates were dialyzed against PBS (pH 7.0) for 72 h. The synthesis
of the coating antigens of hapten7−8 was conducted similarly except
that the KLH was replaced with BSA.
The conjugation ratios of the hapten−BSA conjugates were
calculated using MALDI−TOF−MS by comparing the observed
molecular weights (MW) of the resulting conjugates with that of the
native protein.
(+)
90% yield. HRMS (m/z) calc. For C24H37NO5 419.56, found
1
420.00; H NMR (300 MHz, DMSO-d6) δ (ppm) 11.99 (br, s, 1H,
COOH), 8.19 (t, 1H, NH), 6.88−6.71 (dd, 2H, J = 12 Hz, CHar),
6.84 (s, 1H, CHar), 5.36−5.33 (m, 2H, −HCCH−), 4.19−4.17 (d,
2H, CH2), 3.92−3.88 (t, 2H, CH2), 3.73 (s, 3H, CH3), 2.25−2.20 (m,
3H, CH2, CH), 2.14−2.09 (t, 2H, CH2), 1.95−1.93, (q, 2H, CH2),
1.72−1.67 (m, 2H, CH2), 1.58−1.49 (m, 4H, CH2, CH2), 1.43−1.23
(m, 4H, CH2, CH2), 0.94−0.84 (dd, 6H, CH3, CH3).
Hapten2 was synthesized similar to that described for hapten1.
DCPC was reacted with ethyl 6-bromohexanoate to obtain hapten2
Production of mAbs. Eight 8-week-old female BALB/c mice per
immunogen were immunized according to our previously described
procedure.22 Briefly, the first injection was 100 μg immunogen
emulsified with CFA followed by three subcutaneous injections of 100
μg immunogen with IFA (Table S2). Starting from the second
immunization, mouse antisera samples were collected in the tenth day
after each immunization, and the affinity and specificity were detected
by icELISA. After the fourth immunization, the mice exhibiting the
highest affinity were sacrificed for subsequent cell fusion. The
experimental procedures of fusion were described previously by our
group.22 The hybridoma cells were screened for antibody production
using noncompetitive ELISA and icELISA followed by subcloning
based on the limiting dilution method. The clones with high
inhibition were cloned three priors for ascites production. The
antibody was purified from ascites using the affinity chromatography
columns.
Extraction of Antibody Variable Region Sequences,
Homology Modeling, and Molecular Docking. Total RNA was
isolated from the hybridoma cells following the technical manual of
RNeasy Plus Micro Kit (Qiagen Japan Co. Ltd., Tokyo, Japan) and
then reverse-transcribed into cDNA using either isotype-specific
antisense primers or universal primers of SMARTScribe Reverse
Transcriptase (Clontech, Tokyo, Japan). Antibody fragments with
heavy chains and light chains were then amplified by polymerase
chain reaction (PCR). Different sets of primers listed in Table S3
were used for PCR, which was performed with 30 cycles of 95 °C, 60
s; 65 °C, 30 s; and 72 °C, 120 s. Amplified antibody fragments were
cloned into a standard cloning vector separately. Colony PCR was
performed to screen for clones with inserts of correct sizes. Bacteria
liquid were sent to Genscript (Nanjing, China) for sequencing after
the correct single clones were incubated overnight at 37 °C in LB
liquid medium with shaking at 250 rpm. The sanger sequencing
results of single-chain variable fragment antibody (scFv) 2F7 and
3-D structure predictions for scFv 2F7 and 26A1 were generated by
the program Model Antibody of Discovery Studio based on the
primary structure of antibodies. According to the sequence similarity
and identity, the best matching overall template 1f4w and 2ddq had
been used to model antibody framework for 2F7 and 26A1,
respectively, which determined the relative spatial orientation of
light chain and heavy chain. The binding between two proteins (scFv
2F7 and 26A1) and CPC, DCPC, and ethyl-2-methoxyphenol was
performed using CDOCKER of Discovery studio. After docking
ligands into the top-ranked cavity of the antibody, the binding pose of
each complex with the highest score was selected.
Development and Optimization of icELISA. Each well of
microtiter plates was first coated with 100 μL of coating antigen in
carbonate buffer and then incubated at 4 °C overnight. After blocking,
50 μL of CPC standard with serial dilutions and 50 μL of diluted mAb
were added to the wells, and incubation for 30 min at 37 °C was
carried out. After washing two times, 100 μL of diluted HRP-labeled
goat antimouse IgG was then added followed by incubation for 30
min at 37 °C. The TMB substrate was added and incubated for 15
min at 37 °C after further washing. Then the chromogenic reaction
was inhibited using 2 M H2SO4 (50 μL/well), and the optical density
(OD) values of 450 nm were measured.
(+)
with 90% yield. HRMS (m/z) calc. For C24H39NO5 421.58, found
1
422.0; H NMR (300 MHz, DMSO-d6) δ (ppm) 11.99 (br, s, 1H,
COOH), 8.19 (t, 1H, NH), 6.88−6.85 (s, 1H, CHar), 6.84−6.74 (dd,
2H, J = 1.8 Hz, CHar), 4.19−4.17 (d, 2H, CH2), 3.92−3.88 (t, 2H,
CH2), 3.73 (s, 3H, CH3), 2.25−2.20 (t, 2H, CH2), 2.13−2.08 (t, 2H,
CH2), 1.71−1.67 (q, 2H, CH2), 1.72−1.67 (m, 2H, CH2), 1.56−1.40
(m, 7H, CH2, CH2, CH2, CH), 1.24−0.83 (m, 8H, CH2, CH2, CH2,
CH2), 0.86−0.83 (dd, 6H, CH3, CH3).
Hapten3 was synthesized similar to the previous procedure of
hapten1. CPC was reacted with methyl 4-(bromomethyl)benzoate to
(+)
obtain hapten3 with 70% yield. HRMS (m/z) calc. For C26H33NO5
439.55, found 439.9; 1HNMR (300 MHz, DMSO-d6) δ (ppm) 12.99
(br, s, 1H, COOH), 8.29 (t, 1H, NH), 7.97−7.94 (d, 2H, CHar),
7.65−7.62 (d, 2H, CHar), 6.94 (s, 1H, CHar), 6.92−6.71 (dd, 2H,
CHar), 5.35−5.32 (m, 2H, CHCH), 5.14 (s, 2H, CH2), 4.19−4.17
(d, 2H, CH2), 3.78 (s, 3H, CH3), 2.28−2.22 (m, 1H, CH), 2.14−2.09
(t, 2H, CH2), 1.94−1.93 (q, 2H, CH2), 1.54−1.49 (m, 2H, CH2),
1.31−1.29 (m, 2H, CH2), 0.93−0.83 (dd, 6H, CH3, CH3).
Hapten4 was synthesized similar to the previous procedure of
hapten1. DCPC was reacted with methyl 4-(bromomethyl)benzoate
to obtain hapten4 with 90% yield. HRMS (m/z) calc. for
(+)
1
C26H35NO5 441.57, found 441.90; HNMR (300 MHz, DMSO-
d6) δ (ppm) 12.99 (br, s, 1H, COOH), 8.29 (t, 1H, NH), 7.97−7.94
(d, 2H, CHar), 7.56−7.52 (d, 2H, CHar), 6.94 (s, 1H, CHar), 6.92−
6.71 (dd, 2H, CHar), 5.14 (s, 2H, CH2), 4.19−4.17 (d, 2H, CH2),
3.78 (s, 3H, CH3), 2.13−2.08 (t, 2H, CH2), 1.53−1.49 (m, 3H, CH2,
CH), 1.1.23−1.11 (m, 8H, CH2, CH2, CH2, CH2), 0.85−0.83 (dd,
6H, CH3, CH3).
Hapten5 was synthesized as follows: 0.20 g vanillin amine
hydrochloride was added to 6 mL of pyridine and stirred for 10
min. An amount of 0.12 g succinic anhydride was then added to the
mixture and stirred overnight at 80 °C. The reaction progress was
monitored by TLC (ethyl acetate/ methanol, 2:1). The final product
of hapten5 was obtained by filtering and drying. HRMS (m/z) calc.
1
For C12H15NO5Na(+) 275.23, found 275.80; H NMR (300 MHz,
DMSO-d6) δ (ppm) 12.10−10.71 (br, s, 1H, COOH), 9.62−8.50 (br,
s, 1H, OH), 8.24 (t, 1H, NH), 6.82−6.81 (s, H, CHar), 6.71−6.64
(dd, 2H, CHar), 4.16−4.14 (d, 2H, CH2), 3.74 (s, 3H, CH3), 2.46−
2.44 (t, 2H, CH2), 2.38−2.36 (t, 2H, CH2).
Hapten6 was synthesized similar to that described for hapten5.
Vanillin amine hydrochloride was reacted with adipic anhydride to
obtain hapten6. HRMS (m/z) calc. for C14H19NO5Na(+) 303.29,
found 303.90.
The hapten1−6 were conjugated to a protein (KLH, BTG or BSA)
by the active-ester method through their active carboxylic acid groups.
First, the hapten (0.1 mM) was dissolved in 0.5 mL of DMF, and then
NHS (15.0 mg) and DCC (30.0 mg) were added, which was stirred at
room temperature overnight. Then, the solution (activated hapten)
was added dropwise into the dissolved KLH solution (0.001 mM
KLH in 10 mL of PBS), BTG solution (0.001 mM BTG in 10 mL of
PBS), or BSA solution (0.001 mM BSA in 10 mL of PBS),
respectively, and further stirred for 24 h. The conjugates were dialyzed
against PBS (pH 7.0) at room temperature for 72 h. Hapten-KLH
served as immunogens for hapten1−4, while hapten5−6 were
conjugated with BTG as immunogens because of the large amount
of precipitation generated when they reacted with KLH. The hapten−
BSA acted as coating antigens for hapten1−6.
Eight analogues of CPCs shown in Table 1 were used to evaluate
the cross-reactivity (CR) of assay. The CR was calculated using the
formula as follows:
The immunogens of hapten7−8 were prepared by conjugating with
KLH based on the glutaraldehyde method. Briefly, 0.1 mM of hapten
9960
J. Agric. Food Chem. 2021, 69, 9957−9967